Henan Lingrui Pharmaceutical Co.,Ltd.’s Net Profit Rose 35.3% in First Quarter of 2022

Henan Lingrui Pharmaceutical Co.,Ltd. (河南羚锐制药股份有限公司) (600285.SH) reported a net profit of 130.7 million yuan in the first quarter of 2022, up 35.3% year-on-year.

Meanwhile, the company posted 682.1 million yuan in revenue, up 15.7% year-on-year.

At the end of the reporting period, it had 4.1 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 39.9%.